Login / Signup

Sacroiliitis at diagnosis as a protective predictor against disease flare after stopping medication: outcomes of a Southeast Asian enthesitis-related arthritis (ERA) longitudinal cohort.

Kai Liang TehLena DasYun Xin BookSook Fun HohXiaocong GaoThaschawee Arkachaisri
Published in: Clinical rheumatology (2022)
Despite a high proportion of ERA patients achieving CID, only one-third could stop medication with high rates of disease flare. Unfavorable predictors include older age at onset, HLA-B27, and ANA positivity. While sacroiliitis at diagnosis is a negative predictor of CID at 6 months, it is associated with less disease flare after discontinuing medication.
Keyphrases
  • healthcare
  • rheumatoid arthritis
  • adverse drug
  • newly diagnosed
  • type diabetes
  • emergency department
  • patient reported outcomes
  • cross sectional
  • middle aged
  • insulin resistance
  • patient reported